Rachid C. Baz, MD

Rachid C. Baz, MD

Dr. Baz is a very active researcher in the field and is involved in a number of clinical trials as well as the Moffitt Myeloma Working Group (MMWG). He is a frequent lecturer on myeloma for both medical and lay audiences.

Research Focus:
Dr. Rachid C. Baz, MD’s research focuses on malignant hematology and involves the development and implementation of biomarker-driven therapeutics into patient-based phase I and II clinical trials, including early-phase clinical trials in multiple myeloma. In this context, he and his colleagues initiated a clinical trial of a response-adapted therapy in newly diagnosed myeloma patients who are not candidates for high-dose therapy and do not have high-risk disease. He and his team are evaluating several novel agents (novel proteasome inhibitors, novel immunomodulators as well as monoclonal antibodies). Moreover, Dr. Rachid C. Baz, MD has collaborated with outcome researchers (focusing on outcomes to therapy as well as defining optimal sequences of therapy) and with basic scientists (focusing on translational research and new drug development in myeloma).

years treating myeloma: 9

Number of Myeloma Patients Treated Annually: 1000

Details & contact info

Moffitt Cancer Center

H. Lee Moffitt Cancer Center (MCC) USF Citrus Drive
Tampa, FL, United States, 33620

Phone: 1-888-663-3488

View Full Physician Bio

View Website

Send a message to Rachid C. Baz, MD


Thanks to our Myeloma Crowd Community sponsors:

.                         .       .